Survival Outcome of Salvage Therapy with Second-Generation Novel Agents in Patients with Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice

被引：0
|
作者：
Ozaki, Shuji [1 ]
Harada, Takeshi [2 ]
Udaka, Kengo [1 ]
Sekimoto, Etsuko [1 ]
Shibata, Hironobu [1 ]
Shigekiyo, Toshio [1 ]
Yagi, Hikaru [1 ]
Okamoto, Yasunobu [2 ]
Sogabe, Kimiko [2 ]
Oura, Masahiro [2 ]
Fujii, Shiro [2 ]
Nakamura, Shingen [2 ]
Miki, Hirokazu [3 ]
Kagawa, Kumiko [2 ]
Abe, Masahiro [2 ]
机构：
[1] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Tokushima, Japan
[2] Tokushima Univ Hosp, Dept Hematol, Tokushima, Tokushima, Japan
[3] Tokushima Univ Hosp, Div Transfus Med & Cell Therapy, Tokushima, Tokushima, Japan
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5577
引用
收藏
页数：3
相关论文
共 50 条
  • [11] DCEP for relapsed or refractory multiple myeloma after therapy with novel agents
    Park, Silvia
    Lee, Su Jin
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Seok Jin
    Kim, Won Seog
    Kim, Kihyun
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 99 - 105
  • [12] DCEP for relapsed or refractory multiple myeloma after therapy with novel agents
    Silvia Park
    Su Jin Lee
    Chul Won Jung
    Jun Ho Jang
    Seok Jin Kim
    Won Seog Kim
    Kihyun Kim
    Annals of Hematology, 2014, 93 : 99 - 105
  • [13] Salvage therapy with thalidomide for patients with advanced relapsed/refractory multiple myeloma.
    Tosi, P
    Ronconi, S
    Zamagni, E
    Cellini, C
    Tura, S
    Cavo, M
    BLOOD, 2000, 96 (11) : 296B - 296B
  • [14] Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma
    Castelli, Roberto
    Pantaleo, Giuseppe
    Gallipoli, Paolo
    Gidaro, Antonio
    Arquati, Massimo
    Wu, Maddalena A.
    Deliliers, Giorgio Lambertenghi
    ANTI-CANCER DRUGS, 2015, 26 (10) : 1078 - 1082
  • [15] Salvage Therapy with Bortezomib and Dexamethasone in Elderly Patients with Relapsed Refractory Multiple Myeloma
    Castelli, Roberto
    Gallipoli, Paolo
    Gidaro, Antonio
    Maddalena, Wu
    Arquati, Massimo
    Deliliers, Giorgio Lambertenghi
    BLOOD, 2015, 126 (23)
  • [16] Role of Salvage Transplant in Relapsed Multiple Myeloma Patients in the Era of Novel Agents
    Patibandla, Naga Sai Krishna
    Kamran, Amir
    Yellala, Amulya
    Sadashiv, Santhosh
    Berteotti, Gina
    Khan, Cyrus
    Fazal, Salman
    Kaminsky, Anna
    Mewawalla, Prerna
    Lister, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S140 - S141
  • [17] Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma
    Ahn, Jae-Sook
    Jung, Sung-Hoon
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [18] Outcome after second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma.
    Mikhael, JR
    Samiee, S
    Stewart, AK
    Chen, C
    Trudel, S
    Franke, N
    Winter, A
    Chang, H
    Reece, DE
    BLOOD, 2004, 104 (11) : 270A - 270A
  • [19] SALVAGE THERAPY WITH BORTEZOMIB AND DEXAMETHASONE IN VERY ELDERLY PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
    Castelli, R.
    Pantaleo, G.
    Gallipoli, P.
    Arquati, M.
    Wu, M. A.
    Deliliers, G. Lambertenghi
    Cicardi, M.
    HAEMATOLOGICA, 2015, 100 : 740 - 740
  • [20] Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States
    Hari, Parameswaran
    Romanus, Dorothy
    Palumbo, Antonio
    Luptakova, Katarina
    Rifkin, Robert M.
    Linh Mai Tran
    Raju, Aditya
    Farrelly, Eileen
    Noga, Stephen J.
    Blazer, Marlo
    Chari, Ajai
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (02): : 152 - 160
12345